Open Orphan Plc (LON:ORPH) Share Price, News, Chart & Financials

Open Orphan Plc

Sector: Healthcare

Description

Open Orphan Plc (LON: ORPH) is a fast-growing niche CRO (Clinical Research Organisation) pharmaceutical services company. It is one of the leading global firms in the testing of vaccines and antivirals through the use of human challenge clinical trials. In 2019, it bought Venn Life Sciences Holdings Plc, an integrated drug development consultancy, in a reverse takeover. In January 2020, Open Orphan completed the merger with hVIVO Plc, a global player known for testing the effectiveness of antivirals, vaccines, and respiratory disease agents. Established in 2017 and led by a team of experienced professionals, the company has offices in London, Dublin, Paris and the Netherlands. It is a part of the FTSE AIM All-Share.

Peers

OPTI

OptiBiotix Health PLC

PRTC

PureTech Heath Plc

CIZ

Cizzle Biotechnology Holding Plc

APH

Alliance Pharma plc

IDHC

Integrated Diagnostics Holdings PLC

AMYT

AMRYT PHARMA PLC

ABC

ABCAM PLC

CLIN

CLINIGEN GROUP

MHC

MyHealth Checked PLC

STX

SHIELD THERAPEUTICS PLC

MXC

MGC Pharmaceuticals

EAH

ECO ANIMAL HEALTH GROUP PLC

Close

Open Orphan Plc

Open Orphan Plc

Description

Peers

OPTI

PRTC

CIZ

APH

IDHC

AMYT

ABC

CLIN

MHC

STX

MXC

EAH

Sponsored Articles

Related Articles